FDA Upgrades Recall on More Than 33,000 Bottles of Blood Pressure Drugs Nationwide
"The FDA said the reason for the recall is that the 'product failed to meet dissolution acceptance criteria in the stability studies at the 6th month.'"
The post FDA Upgrades Recall on More Than 33,000 Bottles of Blood Pressure Drugs Nationwide appeared first on Healthcare Communications Network.